Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00434395 · ClinicalTrials.gov registry record · Phase 1
Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects
A Phase 1 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00434395 is a Phase 1 study that has completed, run by Bausch Health Americas.
The verdict
NCT00434395, a Phase 1 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of the study is to assess the effects of MOA-728 on cardiac repolarization in healthy subjects.
Interventions
- DRUG MOA-728
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-03 |
| Est. Completion | 2007-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00434395
The ClinicalTrials.gov registry entry for NCT00434395 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MOA-728 is the first listed.
NCT00434395 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00434395 about?
NCT00434395 is a clinical study titled "Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects". The purpose of the study is to assess the effects of MOA-728 on cardiac repolarization in healthy subjects.
What is the current status of trial NCT00434395?
This trial is currently completed. It is a Phase 1 study. The study started on 2007-03. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00434395?
The interventions under investigation include: MOA-728 (DRUG).
Who is sponsoring clinical trial NCT00434395?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.